- Home
- THRD vs JILL Comparison
THRD vs JILL Comparison
Compare THRD & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- JILL
- Stock Information
- Founded
- THRD 2019
- JILL 1959
- Country
- THRD United States
- JILL United States
- Employees
- THRD N/A
- JILL N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- JILL Clothing/Shoe/Accessory Stores
- Sector
- THRD Health Care
- JILL Consumer Discretionary
- Exchange
- THRD Nasdaq
- JILL Nasdaq
- Market Cap
- THRD 157.7M
- JILL 342.2M
- IPO Year
- THRD 2022
- JILL 2017
- Fundamental
- Price
- THRD $3.45
- JILL $18.22
- Analyst Decision
- THRD Buy
- JILL Strong Buy
- Analyst Count
- THRD 3
- JILL 6
- Target Price
- THRD $14.00
- JILL $38.17
- AVG Volume (30 Days)
- THRD 435.5K
- JILL 84.7K
- Earning Date
- THRD 03-25-2025
- JILL 03-19-2025
- Dividend Yield
- THRD N/A
- JILL 1.14%
- EPS Growth
- THRD N/A
- JILL 24.73
- EPS
- THRD N/A
- JILL 2.82
- Revenue
- THRD N/A
- JILL $614,918,000.00
- Revenue This Year
- THRD N/A
- JILL $2.96
- Revenue Next Year
- THRD N/A
- JILL $3.03
- P/E Ratio
- THRD N/A
- JILL $6.52
- Revenue Growth
- THRD N/A
- JILL 1.57
- 52 Week Low
- THRD $3.18
- JILL $18.04
- 52 Week High
- THRD $16.94
- JILL $40.61
- Technical
- Relative Strength Index (RSI)
- THRD 30.03
- JILL 15.74
- Support Level
- THRD $3.36
- JILL $20.93
- Resistance Level
- THRD $3.65
- JILL $21.90
- Average True Range (ATR)
- THRD 0.14
- JILL 1.03
- MACD
- THRD 0.16
- JILL -0.42
- Stochastic Oscillator
- THRD 35.48
- JILL 2.49
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.